Drug intelligence / Profile preview

Liuwei Muxiang Wan

Development stage: Unknown
Lead developer: Xizang Ganlu Tibetan Medicine
Modality: Small Molecules
Administration: Oral

Overview

Liuwei Muxiang Wan is a traditional Tibetan medicine manufactured by Xizang Ganlu Tibetan Medicine. It is an oral pill formulated from six primary ingredients, typically including *Aucklandia costus* (Muxiang), pomegranate seed, cardamom, long pepper, chebulic myrobalan, and rock salt. In Tibetan medical theory, it is used to warm the stomach, dispel cold, and promote digestion. It is primarily indicated for gastrointestinal disorders such as indigestion, abdominal distension, and gastric pain associated with 'stomach-cold' patterns. The product is officially approved for clinical use in China under the National Drug License Number Z54020033.

Brand names: Ganlu
Other names: 六味木香丸Muxiang Liuwei WanMuxiang Drupa

Beyond the preview

Go deeper on Liuwei Muxiang Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liuwei Muxiang Wan.

Explore the full profile